期刊文献+

3拷贝鸡胸腺素α1基因在大肠杆菌中的融合表达及活性分析

Prokaryotic expression and activity analysis of three tandem chicken thymosin alpha 1 fusion protein
在线阅读 下载PDF
导出
摘要 为表达鸡胸腺素α1(Thymosin alpha l,Tα1),并对其进行纯化及生物学活性分析,本研究根据大肠杆菌基因密码子偏嗜性对Tα1基因进行优化,人工合成了Tα1三拷贝融合基因。并将其克隆至原核表达载体pET-30a中,转化至BL21(DE3)菌株,经IPTG诱导表达和镍柱纯化,获得融合蛋白。融合蛋白经羟胺切割后获得Tαl单体。将单体Tα1按高、中、低3个剂量肌肉注射160只7日龄非免疫商品肉鸡,于不同日龄比较Tα1单体对鸡体内淋巴细胞刺激指数(SI)的影响。结果显示,鸡Tα1三串体为约19 ku大小的融合蛋白,单体约为3.0 ku,与天然Tα1相符。活性分析结果显示,0.03 mg/kg、0.06 mg/kg和0.12 mg/kg 3个剂量的Tα1均能提高鸡体内SI,其中21日龄、28日龄、35日龄各试验组与对照组相比均表现差异显著(p<0.05),以高剂量组最为明显,各试验组间差异不显著。研究表明,通过表达串联体基因方式制备有活性的Tα1是可行的,为Tα1进一步在兽医临床应用提供依据。 To express thymosin alpha 1(Tα1),and identify its bioactivity,a codon optimized triple-copy fusion gene of chicken Tα1 was chemically systhesized according to the published sequence with hydroxylamine schizolysis site between each copy.The fusion gene was cloned into pET-30a and transformed into BL21(DE3) for expression.The fusion protein was expressed with IPTG induction and purified by NI-NTA.The Tα1 monomer was prepared by cleavaged with hydroxylamine.A total of 160 chickens was divided into 4 groups and injected at high,middle and low dose,respectively,to detect the lymphocyte stimulating index(SI) in different period.The results showed that the fusion protein was 19 ku,monomer was 3.1 ku.The difference of SI were significant between experiment groups and control group(p0.05) and the high dose group was better than that of other groups.Therefore,it is a feasible method in perparing micromolecule polypeptide by fusion expression.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2011年第2期150-153,共4页 Chinese Journal of Preventive Veterinary Medicine
基金 青岛城阳区科技发展计划课题(2006-NY-4)
关键词 鸡胸腺素 大肠杆菌 融合表达 纯化 活性分析 chicken thymosin Escherichia coli fusion expression purification activity analysis
  • 相关文献

参考文献9

二级参考文献45

  • 1王勤,杨金波,沈剑敏,文永均,胡晓愚.胸腺肽α_1活性片段和其自旋标记衍生物的合成及免疫活性研究[J].生物化学杂志,1995,11(2):214-218. 被引量:6
  • 2张符光,刘佃辛.胸腺和胸腺素研究进展[J].国外医学(免疫学分册),1996,19(4):187-191. 被引量:21
  • 3Sherman KE,Sjogren M, Creager RL, et al. Combination therapy with thymosin ctl and interferon for the treatment of chronic hepatitis C infection:a randomized ,placebo controlled double- blind trial. Hepatology, 1998,27 : 1128.
  • 4GaraCi E, Lopz M, Bonsignore G, et al. Sequential chemoimmu-notherapy for advanced non - small cell lung cancer using cisplatin, etopiside, thymosinctl and interferon -α2a. Eur J Cancer, 1995,31A(13/14) :2403.
  • 5Rasi G,Terzoli E, Izzo F, et al. Combined treatment with thymosin αl and low - dose interferon - alpha after dacarbazine in advanced melanoma. Melanoma Res ,2000,10( 1 ) : 1.
  • 6Garaci, E. , Rocchim, G. , Perroni L, et al. Combination treatment with zidovudine, thymosin alphal and interferon - alpha in human immunodeficiency virus infection. Int. J. Clin. Lab. Res. , 1994,24(1) :23.
  • 7Hitoshi Ohmori, Masako Kamo, Kimi Yamakoshi, et al. Restoration of immunocyte funetions by thymosin αl in cyelophosphamide-induced immunodeficient mice. Immunopharmacology and Immunotoxicology ,2001,23 ( 1 ) :75.
  • 8Chun - Lin Li ,Ting Zhang,Toshiji Saibara,et al. Thymosin αl accelerates restoration of T cell - mediated neutralizing antibody response in immunocompromised hosts. Int. J. Immunopharma,2002, 2(1) :39.
  • 9Baumann CA, Badamchian M, Gold stein AL. Thymosin αl antagonizes dexamethasone and CD3 - induced apoptosis of CD4 + CD8 + thymocytes through the activation of cAMP and protein kinade c - dependent second messenger pathway. Mech Age Dev,1997,94 : 85.
  • 10RoyR,Singh SM, Shanker A, et al. Mechanism of thymocyte apoptosis induced by serum of tumor - tearing host the molecular events involved and their inhibition by thymosin alpha - 1. Int J Immunopharmaco1,2000,22 (4) :309.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部